ArticleJournal of controlled release : official journal of the Controlled Release Society2018

Resistance to receptor-blocking therapies primes tumors as targets for HER3-homing nanobiologics.

Jessica D Sims et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.